Celyad Oncology SA (CYAD.BR) - Stock Prices, Stock Peers & Analysis

Home
CYAD.BR

Company Name	Celyad Oncology SA
Symbol	CYAD.BR
Currency	EUR
Price	0.25
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	10,357,150
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.212 - 0.84
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Georges Rawadi
Website	https://www.celyad.com

An error occurred while fetching data.

About Celyad Oncology SA

Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer;